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Summary
The establishment of a multi-cellular body plan requires coordinating changes in cell adhesion and
the cytoskeleton to ensure proper cell shape and position within a tissue. Cell adhesion to the
extracellular matrix (ECM) via integrins plays diverse, essential roles during animal
embryogenesis and therefore must be precisely regulated [1]. Talin, a FERM-domain containing
protein, forms a direct link between integrin adhesion receptors and the actin cytoskeleton, and is
an important regulator of integrin function [2]. Similar to other FERM proteins, talin makes an
intramolecular interaction that could autoinhibit its activity [3–6]. However, the functional
consequence of such an interaction has not been previously explored in vivo. Here, we
demonstrate that targeted disruption of talin autoinhibition gives rise to morphogenetic defects
during fly development and specifically that dorsal closure (DC), a process that resembles wound
healing, is delayed. Impairment of autoinhibition leads to reduced talin turnover at and increased
talin and integrin recruitment to sites of integrin-ECM attachment. Finally, we present evidence
that talin autoinhibition is regulated by Rap1-dependent signaling. Based on our data we propose
that talin autoinhibition provides a switch for modulating adhesion turnover and adhesion stability
that is essential for morphogenesis.
Results and Discussion
Integrins connect to the cytoskeleton through an intracellular adhesion complex (IAC);
changes to the protein composition and interactions within the IAC have important
implications for integrin-dependent cellular behaviors [1, 7–9]. Talin is an essential IAC
component [2, 10] containing a conserved, integrin-binding FERM domain at its N-
terminus, and an actin-binding domain at the C-terminus of its helical rod domain [2].
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Structural studies identified residues in both the talin FERM and rod domains that mediate
autoinhibition (Figure 1A) [4, 5]. The same region of the talin FERM domain that binds
integrin also binds the rod to mediate autoinhibition [5]. It has been proposed that talin
autoinhibition may provide a mechanism to down-regulate talin-dependent integrin
activation and blocking talin autoinhibition leads to integrin activation [4,5]. The biological
role of talin autoinhibition is currently not well defined but initial results in cell culture
suggest that it plays an important role as expression of autoinhibition-impaired talin results
in increased integrin activation and altered cell spreading [4, 11].
We hypothesized that the mechanism of autoinhibition is conserved between flies and
vertebrates. The autoinhibitory regions have been mapped to the F3 lobe of the FERM
domain (residues 309–400 in Human Talin1; 318–409 in Drosophila Talin), and a region of
the rod called R9, which forms an amphipathic helical bundle (residues 1655–1826 in
mammals; 1662–1831 in fly) [5]. The F3 domain is highly conserved across species, with
85.7% protein sequence similarity and 74.7% identity between human Talin1 and fly talin
(Figure S1A). The protein sequence of R9 is also highly conserved with 56.3% similarity
and 33.5% identity (Fig. S1B). We used homology modeling to predict the structure of the
rod R9 domain based on the NMR structure of mouse talin and found the fly structure
closely resembles that of mouse (Fig. 1B,C). Notably, four negatively charged surface
residues in the rod that are important for autoinhibitory interactions between the FERM and
the rod domains are conserved in sequence and arrangement between flies and humans (Fig.
1B,C). To quantify differences in secondary structure between the mouse NMR structure
and the predicted fly structure, we calculated the root-mean square deviation (RMSD) of the
superposition of the two structures (Fig. 1D). We obtained a RMSD of 0.148Å for 635
aligned atoms suggesting the two structures are very similar. Homology modeling of the
FERM domain also showed excellent conservation between fly and vertebrate (P.L. &
F.V.P; data not shown). We also used NMR spectroscopy to show that the fly R9 domain
adopts a stable globular conformation in vitro, similar to the mouse protein homolog (Fig.
1E,F). Altogether, our homology modeling and NMR data suggest that the domains of
mammalian talin and fly talin involved in autoinhibition are likely structurally conserved.
Importantly, NMR spectroscopy confirmed an interaction between F2-F3 and R9 of fly talin
(Fig. 1G). This result further confirms the notion that this interaction, which mediates
autoinhibition, is conserved between flies and vertebrates.
We sought to design a fly mutant that would specifically disrupt talin autoinhibition. In the
R9 domain, we chose to introduce a mutation that was shown, in vitro, to completely
abrogate binding with the FERM domain and thus block autoinhibition [5]. This mutation
changes a conserved glutamate residue in R9 (E1777 in fly; E1770 in mammalian talin) to
an alanine residue (E1777A). NMR analyses demonstrated that the spectra of the region of
talin containing the E1777A strongly resembled the spectra of the wild-type region
indicating that the mutation does not disrupt protein folding (Fig. 1F). It was not feasible to
choose a mutation in the FERM domain to abrogate autoinhibition for two reasons. Firstly,
there have only been two mutations in the FERM domain that have been described to disrupt
autoinhibition: the role of the first, M319A (equivalent to M328 in flies), is the subject of an
unresolved dispute [4, 5, 12]. Secondly, the other mutation described to disrupt
autoinhibition K324D [5] (equivalent to K333D in flies) is adjacent to a residue that is
critical for talin function (L325 in vertebrates; L334 in flies) [11, 13,14]. Moreover, this
region of the FERM domain is packed with interaction sites for talin binding partners
(Supplemental Fig. S1A). These factors would make it very difficult to interpret, in vivo, the
phenotype of mutations in the FERM domain that disrupt talin autoinhibition.
To assess the role of talin autoinhibition, wild-type (WT) endogenous talin was replaced in
developing Drosophila embryos with rescue transgenes containing the E1777A mutation
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(see Supplemental Experimental Procedures). Previous analysis has shown that a
ubiquitously expressed WT talin rescue transgene (talinGFP) rescues the embryonic lethality
that results when embryos lack both maternal and zygotic talin protein ([9]; Fig. 1H,I). In
comparison TalinGFP*E1777A failed to rescue the lethality associated with loss of talin
(Fig. 1J,K). The ability of talin transgenes to rescue talin mutants was assayed in the context
of three different integrin-dependent processes. Two of these, DC and Germband Retraction
(GBR), represent dynamic morphogenetic processes while the third, muscle attachment,
represents stable long-term adhesion. While talinGFP fully rescued GBR and DC,
TalinGFP*E1777A only gave a partial and inconsistent rescue (Fig. 2L,M). DC occurs late
in fly embryogenesis and involves the migration of two epidermal sheets over an extra-
embryonic epithelium called the amnioserosa (AS); the AS actively contributes to DC [15,
16]. The end result of DC is to create a continuous epidermis on the dorsal side of the
embryo. Of embryos rescued with talinGFP*E1777A 27.3% (n=99) failed to complete DC
compared with 49.2% (n=53) of talin null embryos and 8% (n=57) of talinGFP rescued
embryos (Fig. 2L). However, closer examination of earlier stage embryos revealed a more
penetrant phenotype (Fig. 2N-O); DC normally concludes at stage 15 in talinGFP-rescued
embryos (89% completion rate/stage 15; n=9) but this was not the case for the majority of
talinGFP*E1777A rescued embryos (22.2% completion rate/stage 15; n=18). Therefore,
talin mutants rescued with talinE1777A exhibited delayed DC (Fig. 2O). We confirmed that
DC was delayed in talinGFP*E1777A rescued talin mutants using live time-lapse imaging
of rescue embryos (Fig. 2N, Movies S1–S2).
A possible explanation for the delayed and incomplete DC observed in TalinGFP*E1777A-
rescued embryos is insufficient expression of the mutant talin. Quantitative RT-PCR
analysis revealed that transcript levels of talinGFP and the talinGFP*E1777A mutant were
approximately equivalent (Fig. 2A). Western blot analysis showed that talinGFP*E1777A
protein levels were slightly less than those of the talinGFP WT transgene (Fig. 2B).
However, the mutant transgenic protein is still present at levels that are comparable to, and
even slightly higher than, the levels of endogenous talin protein since the use of the ubi
promoter results in slight over-expression of both talinGFP*E1777A and TalinGFP relative
to endogenous protein (Fig 2B-C). Intriguingly, we observe a slight difference in size
between talinGFP and talinGFP*E1777A, but we have no evidence to suggest that this has
any functional consequence. Importantly, we could not detect a reduction in talin levels via
antibody staining at myotendinous junctions (MTJs) suggesting that talinGFP*E1777A
transgene expresses sufficiently (Fig. S2). We also quantified the recruitment of WT
talinGFP and talinGFP*E1777A to the prominent integrin adhesions at the MTJs of
embryonic muscles using our established protocol [9, 17]. TalinGFP*E1777A was recruited
to sites of integrin-mediated adhesion at MTJs better than TalinGFP (Fig. 2D-F). This result
is reminiscent of recent reports in cultured cells showing that mutating the talin rod to
prevent autoinhibition results in increased talin localization in the membrane fraction [12].
Altogether, the defects we observe in talinGFP*E1777A mutant embryos are likely not
caused by reduced expression and/or mislocalization of talin but by the specific effects of
the mutation.
To investigate whether the TalinGFP*E1777A impairs the assembly of the IAC and/or its
attachment to the ECM we analyzed the fly MTJs as they provide an established and
quantitative model to study disruptions in IAC recruitment and ECM attachment [9, 17–19].
We did not find any defects in MTJ integrity, IAC recruitment or ECM attachment in talin
mutant embryos rescued with TalinGFP*E1777A (Fig. S2A-E,I-O). Previous studies
suggested that the ability of talin to autoinhibit might comprise a mechanism to modulate
vinculin recruitment and actin association. However, we were unable to find any differences
in either actin or vinculin recruitment (Fig. S2D-E,I-L). Additionally, vinculin was not
expressed in the AS providing further evidence that a disruption in vinculin binding to talin
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was unlikely to underlie the dorsal closure defects we observed in the talinGFP*E1777A-
rescued embryos (Fig. S2F). We also used gel filtration to confirm that the R9 of the rod
domain does not bind vinculin in vitro (Fig. S1G,H).
Defective morphogenesis could result from improper regulation of stability and turnover of
integrin-mediated adhesions. To test this, we studied the adhesion dynamics exhibited by the
autoinhibition defective talinGFP*E1777A using our previously established Fluorescence
Recovery After Photobleaching (FRAP) protocol to examine the turnover of integrin and
IAC components at MTJs in living Drosophila embryos and larvae [18]. FRAP analysis
revealed that talinGFP*E1777A is more stable at MTJs than WT talinGFP (Fig. 2G). This
data suggests that talin autoinhibition can modulate the turnover of integrin-based adhesion
and that, specifically, preventing talin autoinhibition stabilizes the adhesion complex.
Further examination of integrin-mediated adhesions in the AS supported this idea. We found
that embryos rescued with talinGFP*E1777A exhibited greater integrin recruitment to the
membrane of AS cells (Fig. 2H, J-K) and also to the leading edge of the epidermal cells that
crawl over the AS (Fig. 2L-N). We also observed increased co-localization of talin and
integrin in the AS (Fig. 2I-K). These observations are in line with reports in culture that
expression of the talinE1770A autoinhibition mutant resulted in increased focal adhesion
assembly [11].
Our results indicated a link between autoinhibition and the regulation of the turnover and
stability of integrin-based adhesions. The signaling molecules FAK and Rap1 have been
implicated in such regulation [20–22] and we sought to see if either effector acts to regulate
talin autoinhibition. Analysis of FAK failed to show any phenotypic parallels or genetic
interactions with talin autoinhibition; loss of FAK does not lead to defects in embryogenesis
or disrupt viability [23]. Moreover, modulation of FAK activity does not impinge on
turnover of either WT talin or the talinE1777A at MTJs (Fig. S3). We also tested the small
GTPase Rap1, which has been implicated as part of a putative complex that localizes talin
from the cytoplasm to adhesion complexes at the plasma membrane [24, 25] where it has
been speculated autoinhibition can be relieved [14, 26, 27]. Our hypothesis was that
increasing Rap1 activity would give rise to similar phenotypes to those observed in
talinEGFP*E1777A-rescued embryos. To test this, we expressed a constitutively-active
form of Rap1 (Rap1-Q63E; Rap1-CA) in the AS using the tissue specific Gal4 driver, c381;
we observed similar DC defects to those seen with the autoinhibition defective talin (Fig. 3).
Specifically, more than 60% of the Rap1-CA expressing embryos had open dorsal holes at
the end of stage 15 with about 20% of the embryos failing to complete DC altogether
(Figure 3A-B). We confirmed this delay using time-lapse imaging (Fig. 3A, Movie S3–4).
Furthermore, we found that colocalization of integrin and talin was increased in integrin-
mediated adhesions of AS cells expressing Rap1-CA – this manifested itself as an increase
in integrin signal at the membrane (Fig. 3C-F). We also tested the effect of expressing a
dominant-negative form of Rap1 (Rap1-S17A; Rap1-DN) specifically in the AS and found
that it also gave rise to DC defects. However, the Rap1-DN phenotype is different from that
observed with the Rap1-CA in two ways: i) DC was not delayed but rather failed outright
and ii) other morphogenetic problems, such as failed GBR, were observed (Fig. S4). Our
data is consistent with previous work showing that expressing either Rap1-CA or Rap1-DN
in the fly epidermis impairs DC, though the severity and range of phenotypes observed was
different [28]. Altogether, these results indicated that Rap1 modulates integrin adhesion in
the AS and is required for DC.
In addition to regulating integrin recruitment to the membrane in the AS, we also found that
Rap1-CA increased the recruitment of talinGFP to MTJs (Fig. 3G). Therefore, we predicted
that Rap1 might also regulate IAC turnover. FRAP analysis of talinGFP dynamics at MTJs
revealed decreased turnover upon expression of Rap1-CA in the muscle (Fig. 3I). In
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comparison, expression of Rap1-DN elicited the opposite effect: turnover of talinGFP
increased (Fig. 3J). To test whether Rap1 conferred its effect upstream of talin
autoinhibition, either Rap1-DN or Rap1-CA were expressed in the presence of the talin
autoinhibition mutant, talinGFP*E1777A. We found that Rap1-CA did not affect
talinGFP*E1777A recruitment (Fig. 3H) and that neither Rap1-CA nor Rap1-DN modulated
talinGFP*E1777A turnover (Fig. 3K,L). These results suggest that active Rap1 increases
talin recruitment to and stabilization at cell-ECM adhesions, and that this effect occurs
upstream of talin autoinibition.
It has been shown that the MRL-family protein RIAM links membrane targeting sequences
in Rap1 to talin, thereby recruiting talin to the plasma membrane which leads to activation
of integrin and enhanced adhesion [24, 29]. In general, the functions assigned to RIAM,
including recruiting talin to the membrane and promoting stable adhesions are similar to
those obtained by the relief of autoinhibition [12, 25, 29, 30]. Comprehensive analyses of
the embryonic role of the Drosophila RIAM homolog, pico, are precluded at this time
because the original loss of function allele has been lost (D. Bennett, personal
communication). To circumvent this problem and to test whether RIAM may also be
involved in Rap1-dependent regulation of talin autoinhibition in the fly, we developed
alternative approaches to modulate Pico/RIAM levels in the embryo. First, we used a
minimal RIAM-Rap1 chimera (Fig. 4A; “RIAM30-CAAX”) comprised of the first 30 amino
acids of human RIAM, which contains a talin binding site, and the membrane-targeting
CAAX sequence of Rap1a, that was previously shown to be sufficient to activate integrins in
CHO cells [24]. We found that expression of RIAM30-CAAX in the AS leads to delays in
dorsal closure: approximately 80% of embryos exhibited open dorsal sides at the end of
stage 15 (Fig. 4B-C). Furthermore, we found that RIAM30-CAAX induced increased
recruitment of talinGFP to the membrane (Fig. 4D), and that the turnover dynamics of
talinGFP decreased (Fig. 4G). The phenotypes conferred by increasing pico/RIAM via
RIAM30-CAAX closely resembled those elicited by both the talinGFP*E1777A mutant and
Rap1-CA suggesting that pico/RIAM could play a similar role in regulation of talin
function. The ability of a human protein chimera to work as well as it does in flies illustrates
the conservation of this system throughout evolution. Second, using an RNAi-induced
knockdown of pico in the muscles, we found that the turnover of talinGFP increased (Fig.
4F,H), recapitulating the observed effect of expressing Rap1-DN. Importantly, neither the
recruitment of talinGFP*E1777A to the membrane (Fig. 4E) nor the turnover dynamics of
talinGFP*E1777A changed upon modulation of pico/RIAM (Fig. 4I-J), indicating that, like
Rap1, Pico/RIAM modulates talin behavior via an autoinhibition-dependent mechanism. We
propose that Rap1 and RIAM act upstream of talin to relieve autoinhibition; this promotes
its recruitment to sites of adhesion where it forms a stabilizing link between integrins and
the cytoskeleton (Fig. 4K). Our results also support the notion that a non-autoinhibited talin
molecule can be recruited independent of Rap1/RIAM activity.
Overall, this study identifies an important role for the regulation of talin function through
autoinhibition. Failure to autoinhibit talin impairs morphogenetic processes but this is not
due to defects in integrin-mediated attachment to the ECM or in the assembly of the
adhesion complex. Thus it is unlikely that the E1777A mutation blocks integrin-mediated
Cell-ECM attachment in a dominant negative fashion. An alternative explanation for the
phenotype is that the E1777A mutant behaves like a gain of function allele of talin, and that
the morphogenetic defects we observe are due to too much rather than too little adhesion.
This would not be the first time such a phenomenon has been observed, for example
overexpression of integrins in either the wing or the muscle gives rise to phenotypes
identical to those found in integrin null mutants [17, 31]. How could the E1777A mutation
give rise to stronger adhesion? We show that this mutation enhances the recruitment and co-
localization of talin and integrin at sites of adhesion. Importantly, we show that the E1777A
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mutation effectively reduces talin turnover at sites of adhesion. Indeed, our data fits with a
gain-of-function model: blocking talin autoinhibition leads to increased integrin-mediated
adhesion, and this impairs morphogenetic processes that require cyclic adhesion assembly
and disassembly. Further consistent with this model is the observation that adhesion at
MTJs, a non-morphogenetic context, is not perturbed upon blocking autoinhibition of talin.
We cannot exclude the possibility that E1777A may confer its effect on talin function
through a means other than disruption of autoinhibition. Encouragingly, however, our
homology modeling and NMR analyses strongly suggest that the fly protein behaves much
as the mammalian homolog does.
How does preventing autoinhibition stabilize integrin-mediated adhesion? We show that
autoinhibition regulates talin recruitment to adhesions through a RIAM-Rap1 dependent
mechanism. Interestingly, the E1777A autoinhibition mutant talin is more strongly recruited
to adhesions than WT talin; this enhanced recruitment occurs independent of RIAM-Rap1
activity. Thus, it is possible that constitutively relieving autoinhibition works to stabilize and
promote adhesion by enhancing recruitment of the talin molecule to adhesions, thus
bypassing the need of the RIAM-Rap1 pathway for recruitment. At the membrane, adhesion
strengthening may occur via talin’s scaffolding function, as talin can interact with multiple
components of the IAC, and these interactions may increase and/or change when talin
assumes a more extended conformation. Another possibility, consistent with structural
studies, is that relieving autoinhibition frees up the FERM/IBS-1 domain of talin such that it
can activate integrins [4, 5]. We would predict that mutations in talin that block IBS-1-
mediated integrin activation would lead to more dynamic adhesions, and this is indeed what
was observed [9]. According to the model we envision, talin recruitment is determined by
the sum of interactions that a single molecule can make with other IAC components at any
one time. For example, the autoinhibited form of talin relies on Rap1/RIAM for efficient
recruitment, even though it may still bind integrin through its free IBS-2 domain [9]; both
mechanisms may contribute to targetting of talin to adhesions. We speculate that relieving
autoinhibition makes the IBS-1 available, as well as the many other binding sites for IAC
components that are found in the talin rod domain (e.g. vinculin binding sites), thereby
substantially increasing the number of possible interactions that can lead to talin recruitment
to the IAC.
There are likely multiple avenues leading to relief of talin autoinhibition. Recent super-
resolution studies provided elegant evidence that autoinhibition is primarily relieved within
adhesion complexes [27], implicating the need for a mechanism to specifically recruit
autoinhibited talin to adhesions. Here we show that forcing talin to remain in an open, non-
autoinhibited conformation gives rise to very similar phenotypes as activating the RIAM-
Rap1 pathway. Based on the results obtained by us and other groups [6, 14, 25, 27, 29, 32,
33], we propose that RIAM-Rap1 brings autoinhibited talin to the membrane where
autoinhibition can subsequently be relieved, possibly through electrostatic interactions with
the membrane/PIP2. RIAM-Rap1 has a previously established role in mediating the
recruitment of talin to sites of adhesion, but recently, it has been demonstrated that the
requirement for RIAM-Rap1 is context-dependent. Structural and biochemical studies have
revealed that the binding of talin to either RIAM or vinculin is mutually exclusive and likely
dependent on force [32, 33]. Moreover, in cell culture, vinculin-stimulated integrin
activation is RIAM-Rap1 independent raising the possibility that more mature adhesions
might not need RIAM-Rap1 to promote talin activation in this case [32]. Along similar lines,
we demonstrate that RIAM-Rap1 activity is dispensable for recruitment of a non-
autoinhibited talin molecule.
In summary, our results suggest that talin autoinhibition confers a switch through which fine
control of integrin-mediated adhesion can be exerted in vivo. Our findings also reveal
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RIAM-Rap1-mediated regulation of integrin adhesion to be an important modulator of
morphogenesis and provide evidence for an autoinhibition-based pathway for control of talin
function through RIAM-Rap1. Furthermore, this study exemplifies how subtle tuning of
adhesion complex composition and stability elicits different adhesive functions and cellular
behaviors during development.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Talin autoinhibition modulates cell-ECM adhesion stability during
morphogenesis
• Failure to regulate talin autoinhibition results in delayed morphogenesis
• Defect arises as a result of cell-ECM adhesion that is too stable
• Rap1/RIAM signalling acts upstream of talin autoinhibition
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Figure 1. Disruption of a conserved autoinhibitory intramolecular interaction between the talin
FERM and the talin rod leads to morphogenetic defects including delayed dorsal closure
(A) Cartoon schematic of talin autoinhibition. (B-D) The NMR structure[5] of mouse R9 (B)
and our homology-predicted model of fly talin R9 (C). Critical residues for F3-rod binding
are highlighted in red. (D) Superposition of the mouse NMR structure (yellow) and the
homology-modeled fly structure (blue). (E) Coomassie-stained SDS-PAGE gel showing that
purified recombinant WT and E1777A fly R9 domains exhibit similar electrophoretic
mobility at the expected molecular weight. (F) 1H,15N-TROSY-HSQC spectra of 150
µM 15N-labeled WT talin R9 (blue) and R9 E1777A (red). The R9 E1777A mutant shows a
well dispersed NMR spectrum similar to that of the wildtype R9 indicating that the mutation
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does not affect the tertiary structure of the domain. (G) A 1H,15N-TROSY-HSQC spectra of
25 µM 15N-labeled fly talin F2F3 alone (blue) or in the presence of the talin rod R9 domain
(red). In the presence of R9, some of the peaks have shifted and broadened (indicated by
asterisks) compared to the spectra of the free F2F3 providing evidence of a direct interaction
between fly F2F3 and R9. (H-M) Late stage talin-null embryos stained for integrin (green in
H-K) and F-actin (magenta in H-K) were scored for phenotypes in the morphogenetic
processes DC (J,L; asterisk in J demarcates open dorsal hole) and GBR (K,M; arrowhead in
K shows un-retracted tail). Embryos were rescued with talinEGFP (H) construct or the
talinEGFP*E1777A autoinhibition mutant construct (J-K). (N-O). Talin-null embryos
rescued with either talinGFP or talinEGFP*E1777A were scored for dorsal holes at stage
13–17 (see Experimental Procedures). (O) Images from time-lapse movies of WT-rescued
embryos (top) or E1777A mutant (bottom) embryos expressing talinGFP*E1777A and
undergoing DC at the indicated time-points.
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Figure 2. Talin stability and dynamics are compromised by the E1777A autoinhibition mutation
(A-C) qPCR (A) and Western blot data (B-C) for talinEGFP (orange), autoinhibition mutant
talinEGFP*E1777A (purple) and endogenous untagged talin (black). Talin was detected
with a polyclonal antibody raised to the C-terminus (see [10]) and Westerns were done in a
wild-type background. (D-F) The recruitment of talinGFP (D,E) and talinGFP*E1777A
(D,F) at MTJs (C, p<0.01). (F) Fluorescence recovery curves of talinGFP (orange) and
talinGFP*E1777A (purple) obtained from FRAP experiments on embryonic MTJs,
*p<0.001. (G-N) βPS-integrin signal was quantified at the lateral membrane of AS cells (H)
and the leading edge of the epidermis (L) and colocalization of talin (magenta in J’,K’) and
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βPS integrin (green in J’-K’,M’-N’; black in J’-K’,M’-N’) was measured at the lateral
membrane of AS cells using Pearson correlation co-efficients (I; n>25 cells, *p<0.05,
***p<0.001). F-actin is shown in magenta in M’-N’ to highlight the leading edge.
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Figure 3. Rap1 functions upstream of talin autoinhibition during morphogenesis
(A) WT embryos and embryos expressing Rap1-CA in the AS were scored for openings in
the dorsal epidermis at stage 13–17. (B) Images from time-lapse movies of control embryos
(top) or embryos expressing Rap1-CA in the AS (bottom) undergoing DC at the indicated
time-points. (C-F) β-integrin signal localized at the lateral membrane of AS cells was
quantified (C) and colocalization of talin (magenta in E’,F’) and β-integrin (black in E,F;
green in E’,F’) was measured at the membrane of AS cells using Pearson Correlation Co-
efficients (D; n>25 cells, *p<0.05,***p<0.001). (G,H) The recruitment of talinGFP (D) and
talinGFP*E1777A (E) to MTJs was measured in control embryos (orange in G; purple in H)
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and embryos expressing Rap1CA (pink; **p<0.01). (H-K) FRAP experiments were
performed on talinGFP (I,J) and talinGFP*E1777A (K,L) to determine the effect of
expressing either Rap1-CA (I,K) or Rap1-DN (J,L) on the mobility of talin at MTJs.
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Figure 4. Pico/RIAM functions upstream of talin autoinhibition during morphogenesis
(A) Schematic diagram of RIAM30-CAAX (B) WT embryos and embryos expressing
RIAM30-CAAX in the AS were scored for openings in the dorsal epidermis at stage 13–17.
(C) Stage 15 embryo with an open dorsal hole (arrowhead) stained for amnioserosa (green),
integrin (red), and F-actin (blue). (D-E) The recruitment of talinGFP (D) and
talinGFP*E1777A (E) to MTJs in control embryos and embryos expressing RIAM30-
CAAX. (F) To provide evidence of pico knockdown based on the previously described pico
phenotype [34], we measured adult body size of control embryos and embryos expressing
picoRNAi under the control of a ubiquitous driver. (G-J) FRAP experiments were
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performed on talinGFP (G,H) and talinGFP*E1777A (I,J) to determine the effect of
expressing either RIAM30-CAAX (G,I) or picoRNAi (H,J) on the mobility of talin at MTJs.
(M) Model for the role and regulation of talin autoinhibition. RIAM-Rap1 acts to localize
autoinhibited talin to integrin-mediated adhesions where autoinhibition can be relieved by
electrostatic membrane interactions. This mechanism promotes stable adhesion, thus down-
regulating cell motility required for morphogenesis.
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